Further observations on metronidazole (Flagyl).
作者信息
GRAY M S, KANE P O, SQUIRES S
出版信息
Br J Vener Dis. 1961 Dec;37(4):278-9. doi: 10.1136/sti.37.4.278.
Abstract
摘要
相似文献
1
Further observations on metronidazole (Flagyl).关于甲硝唑（灭滴灵）的进一步观察
Br J Vener Dis. 1961 Dec;37(4):278-9. doi: 10.1136/sti.37.4.278.
2
RESULTS OF TREATMENT OF TRICHOMONIASIS WITH METRONIDAZOLE (FLAGYL) IN PRIVATE AND CLINIC PATIENTS.甲硝唑（灭滴灵）治疗滴虫病在私人诊所和门诊患者中的治疗结果。
West J Surg Obstet Gynecol. 1963 Sep-Oct;71:232-3.
3
Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant follow-up).
Am J Obstet Gynecol. 1965 Oct 15;93(4):502-5.
4
LONG-TERM ASPECT OF TREATMENT WITH METRONIDAZOLE (FLAGYL) IN TRICHOMONAL VAGINITIS.甲硝唑（灭滴灵）治疗滴虫性阴道炎的长期效果
Br J Vener Dis. 1963 Dec;39(4):258-60. doi: 10.1136/sti.39.4.258.
5
[Metronidazole (Flagyl) in long-term therapy-resistant trichomoniases].[甲硝唑（灭滴灵）用于长期治疗耐药性滴虫病]
Zentralbl Gynakol. 1962 Dec 8;84:1898-901.
6
TREATMENT OF TRICHOMONAS VAGINITIS BY ORAL METRONIDAZOLE (FLAGYL).口服甲硝唑（灭滴灵）治疗滴虫性阴道炎
J Iowa Med Soc. 1964 Jul;54:344-7.
7
[RESULTS IN THE TREATMENT OF TRICHOMONIASIS WITH FLAGYL].[甲硝唑治疗滴虫病的结果]
Magy Noorv Lapja. 1963 Jul;26:199-202.
8
METRANIDAZOLE (FLAGYL) IN THE TREATMENT OF RESISTANT TRICHOMONIASIS.甲硝唑（灭滴灵）治疗耐药性滴虫病
J Okla State Med Assoc. 1963 Oct;56:462-6.
9
Flagyl (metronidazole).灭滴灵（甲硝唑）。
Br J Vener Dis. 1960 Sep;36(3):154-62. doi: 10.1136/sti.36.3.154.
10
Treatment of trichomonal vaginitis and urethritis and their complications with metronidazole ("Flagyl").用甲硝唑（“灭滴灵”）治疗滴虫性阴道炎、尿道炎及其并发症。
Br J Vener Dis. 1961 Jun;37(2):176-8. doi: 10.1136/sti.37.2.176.
引用本文的文献
1
Clinical pharmacokinetics of metronidazole.甲硝唑的临床药代动力学
Clin Pharmacokinet. 1983 Jan-Feb;8(1):43-62. doi: 10.2165/00003088-198308010-00003.
2
Metronidazole versus anaerobes. In vitro data and initial clinical observations.甲硝唑与厌氧菌。体外数据及初步临床观察。
Calif Med. 1972 Dec;117(6):22-6.
3
Drugs in human milk. Clinical pharmacokinetic considerations.母乳中的药物。临床药代动力学考量
Clin Pharmacokinet. 1988 Apr;14(4):217-40. doi: 10.2165/00003088-198814040-00003.
4
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).新生儿药物生物处置的原则。药代动力学-药效学界面的批判性评价（第一部分）。
Clin Pharmacokinet. 1988 Apr;14(4):189-216. doi: 10.2165/00003088-198814040-00001.
5
Metronidazole excretion in human milk and its effect on the suckling neonate.甲硝唑在母乳中的排泄及其对哺乳新生儿的影响。
Br J Clin Pharmacol. 1988 Jul;26(1):45-51. doi: 10.1111/j.1365-2125.1988.tb03362.x.
6
Prediction of drug distribution into human milk from physicochemical characteristics.根据物理化学特性预测药物在人乳中的分布。
Clin Pharmacokinet. 1990 Feb;18(2):151-67. doi: 10.2165/00003088-199018020-00005.
7
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.甲硝唑及其他硝基咪唑类抗感染药物的临床药代动力学
Clin Pharmacokinet. 1992 Nov;23(5):328-64. doi: 10.2165/00003088-199223050-00002.
8
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.甲硝唑在厌氧菌感染中的应用：对其活性、药代动力学及治疗用途的综述
Drugs. 1978 Nov;16(5):387-417. doi: 10.2165/00003495-197816050-00002.
本文引用的文献
1
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.甲硝唑的吸收与排泄。I. 口服给药后的血清浓度及尿排泄情况。
Br J Vener Dis. 1961 Dec;37(4):273-5. doi: 10.1136/sti.37.4.273.
Zotero 插件